E. Torban et Pr. Goodyer, EFFECTS OF PAX2 EXPRESSION IN A HUMAN FETAL KIDNEY (HEK293) CELL-LINE, Biochimica et biophysica acta. Molecular cell research, 1401(1), 1998, pp. 53-62
PAX2, a member of the ''paired-box'' family of homeotic genes, is a nu
clear transcription factor expressed in the early stages of nephrogene
sis by induced blastemal cells as they progress from mesenchymal conde
nsates to the ''S-shaped'' stage and also by the ureteric bud. Spontan
eous mutations in one copy of PAX2 in humans causes a syndrome of prot
einuric renal failure and coloboma of the eye (P. Sanyanusin et al., N
at. Genet. 9 (1995) 358-363); transgenic mice with disruption of the P
AX2 gene are anephric (M. Torres et al., Development 121 (1995) 4057-4
067. Although PAX2 is clearly critical for normal kidney development,
its direct effects on kidney cell phenotype are unknown. To address th
is issue, we developed stable transfectants of the HEK293 human fetal
kidney epithelial cell line expressing human PAX2 protein under tetrac
ycline-regulatable promoter. In these cells, PAX2 had no effect on the
proliferative rate, but increased the expression of the Wilms' tumor
gene (2-fold) and E-cadherin (7-fold). PAX2 had a strong inhibitory ef
fect on vimentin; vimentin/GAPDH mRNA ratio was suppressed to 8% of co
ntrol whereas cytokeratin-18/GAPDH mRNA ratio was unchanged. During ne
phrogenesis, loss of vimentin and onset of low-level WT1 and E-cadheri
n expression occur in mesenchymal condensates. Our observations sugges
t that these events may be, in part, regulated by PAX2. (C) 1998 Elsev
ier Science B.V.